1. Home
  2. FET vs SLN Comparison

FET vs SLN Comparison

Compare FET & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forum Energy Technologies Inc.

FET

Forum Energy Technologies Inc.

HOLD

Current Price

$39.14

Market Cap

309.5M

Sector

Industrials

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$5.77

Market Cap

318.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FET
SLN
Founded
2005
1994
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
309.5M
318.4M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
FET
SLN
Price
$39.14
$5.77
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$39.67
AVG Volume (30 Days)
132.8K
284.4K
Earning Date
02-19-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$790,292,000.00
$25,830,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
40.39
52 Week Low
$12.78
$1.97
52 Week High
$39.85
$7.87

Technical Indicators

Market Signals
Indicator
FET
SLN
Relative Strength Index (RSI) 69.12 38.74
Support Level $35.70 $5.62
Resistance Level $39.85 $6.46
Average True Range (ATR) 1.86 0.36
MACD 0.15 -0.05
Stochastic Oscillator 91.05 15.45

Price Performance

Historical Comparison
FET
SLN

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: